Léon Bérard Center

What Léon Bérard Center does

Centre Léon Bérard (CLB) is a private not-for-profit comprehensive cancer hospital and research center located at 28 Rue Laennec in Lyon, France, operating since 1923 as an ESPIC (Établissement de Santé Privé d'Intérêt Collectif) under the UNICANCER federation of 20 French cancer centers. CLB is 100% dedicated to oncology across the full care continuum — surgery, chemotherapy, radiation therapy, nuclear medicine (including vectorized radiotherapy with I131, Y90, Lu177 at the LUMEN service), interventional radiology, hematology, and pediatric oncology — and treats more than 42,000 patients annually, with a joint pediatric unit (IHOPe, 51 beds, ~250 new patients/year) operated with Hospices Civils de Lyon.

Its technology backbone includes the Centre de Ressources Biologiques (CRB) and Plateforme de Gestion des Échantillons Biologiques (PGEB), ISO 20387 and ISO 9001 certified, managing approximately 80,000 institutional samples (300,000 tubes) and serving as a hosting node for the UNICANCER biobank, MESOBANK, LYriCAN, and SHARE4kids networks. The facility operates advanced imaging (2 MRI including 3T, 2 CT scanners, 3 mammography rooms), nuclear medicine (2 PET, 3 SPECT/CT including CZT wide-field), validated AI tools for diagnostic precision and treatment personalization, and computer-simulation platforms (UMR CNRS 5220, Inserm U 1044) for radiotherapy optimization, supported by more than 600 researchers.

CLB's revenue is generated through three primary streams: reimbursement from the French national health insurance for clinical care, government and European research grants (INCa, EU programs) plus pharmaceutical clinical-trial partnerships, and tax-deductible donations channeled through a dedicated fundraising portal. It serves adult cancer patients, pediatric and adolescent patients via IHOPe, international patients through a dedicated bureau, and healthcare professionals through referral networks, teleexpertise, and the UNICANCER community of practice, while maintaining teaching and training output for roughly 700 professionals per year in partnership with Université Lyon 1.

Name

Léon Bérard Center

Legal name

Centre Léon Bérard

Website

https://centreleonberard.fr

Company type

Private

Founded year

1923

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Centre Léon Bérard is a French non-profit comprehensive cancer hospital and research center in Lyon, part of the UNICANCER federation, treating over 42,000 oncology patients annually across adult and pediatric care while running an ISO-certified 80,000-sample biobank and AI-enabled clinical research programs.

Ownership category

akta.pro rank

Product category

Oncology Hospital and Cancer Research Services

NAICS

Specialty (except Psychiatric and Substance Abuse) Hospitals (62231), Offices of Physicians (62111), Medical and Diagnostic Laboratories (6215)

SIC

Services-Hospitals (8060), Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Medical Laboratories (8071)

akta.pro primary industry

Oncology & Cancer Specialty Hospitals (HLAFAHAC)

akta.pro secondary industries

Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI), Medical Oncology (HLAKAFAB), Oncology Telemedicine Platforms (HLALAGAH)

Keywords

• Oncology hospital services
• Cancer treatment center
• Clinical cancer research
• Biological sample biobanking
• Pediatric hematology oncology

Headquarters

HQ city

Lyon

HQ country

France

HQ region

Europe

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain, Others

Revenue model

1. Healthcare Services: As an ESPIC (Établissement de Santé Privé d'Intérêt Collectif), the center provides cancer treatment services reimbursed by French national health insurance (Sécurité Sociale). Revenue generated through patient care activities including consultations, hospitalizations, chemotherapy, radiation therapy, and surgical procedures.
2. Research Grants and Funding: Research activities funded through governmental grants, French National Cancer Institute (INCa), European research programs, and partnerships with pharmaceutical companies for clinical trials.
3. Donations and Charitable Contributions: Private donations collected to fund research programs, high-tech equipment, and construction of new research facilities. Tax-deductible donations eligible for 66% income tax deduction or 75% IFI deduction.

Pricing tiers

Go-to-market motion3 records

Distribution channels5 records

Marketing channels11 records

Core offering

The Centre Léon Bérard is a 100% oncology-dedicated hospital and research center in Lyon, France. It delivers comprehensive cancer care (consultations, chemotherapy, radiation therapy, surgery, nuclear medicine, interventional radiology) to over 40,000 patients annually, conducts fundamental, translational, and clinical cancer research through 600+ researchers, and provides medical education and training. It also operates specialized units including a pediatric oncology hospital (IHOPe), supportive care (DISSPO), and an ISO-certified biological resource center (CRB/PGEB) managing 80,000+ samples.

Product overview

Centre Léon Bérard is a comprehensive cancer treatment and research institution operating as a single-site hospital with three integrated missions: patient care (treating over 40,000 patients annually), cancer research (fundamental, translational, and clinical), and medical education. The institution offers specialized departments including medical oncology, hematology, pediatric oncology (IHOPe), radiotherapy, and supportive care (DISSPO). Key research infrastructure includes the certified Biological Resource Center (CRB) with approximately 80,000 samples and the PGEB sample management platform. Patient-facing digital services include the myCLB portal for health records access and a transparency portal for research participation information.

Differentiator

Problem solved

Functional benefit

Brands

• IHOPe (Institut d'Hématologie et d'Oncologie Pédiatrique): Pediatric hematology and oncology institute operated jointly by Hospices Civils de Lyon and Centre Léon Bérard, treating children and adolescents with cancer.
• CRB (Centre de Ressources Biologiques)
• PGEB (Plateforme de Gestion des Echantillons Biologiques)

Products and services

• Comprehensive Cancer Treatment Services Full-spectrum oncology treatment delivered at a single-site hospital in Lyon including consultations, hospitalizations, day hospital services, chemotherapy, radiation therapy, surgery, nuclear medicine, and interventional radiology for adult cancer patients.
• Institut d'Hématologie et d'Oncologie Pédiatrique (IHOPe) Specialized pediatric oncology hospital treating children and adolescents with solid tumors and hematological malignancies. Designated as an INCa-labellised early-phase clinical trial center (CLIP) for pediatric oncology with membership in the ITCC consortium and ERN PedCan.
• Département des Soins de Support du Patient en Oncologie (DISSPO) Integrated supportive care department dedicated to global support of cancer patients through palliative care, pain management, nutrition, and psycho-oncology services combined with research and education.
• Clinical Research and Clinical Trials Program Clinical trials program offering Phase I-IV interventional studies across digestive, head and neck, hematological, and pediatric cancers, conducted by 600+ researchers covering fundamental, translational, and clinical research.
• Centre de Ressources Biologiques (CRB) - Biological Resource Center Certified biological sample collection and management platform that stores and provides access to tumor tissues, biological fluids, cells, and nucleic acids for cancer research, managing approximately 80,000 samples including a tumor bank (14,000), serotheque (47,000), and derived products (22,000).
• Plateforme de Gestion des Echantillons Biologiques (PGEB) Biological sample management platform with 330 square meters, 15 liquid nitrogen tanks, 17 freezers, ISO 20387 and ISO 9001 certified, managing approximately 80,000 institutional samples and 300,000 tubes, with sample preparation, quality control, and national/international distribution services.
• International Patient Services Dedicated international patient office providing cross-border healthcare coordination, second medical opinions via deuxiemeavis.fr partnership, visa and insurance support for patients residing outside France without French social security.
• Medical Education and Professional Training Medical education and professional training programs for healthcare workers, researchers, and students, training nearly 700 professionals annually in partnership with Claude Bernard Lyon 1 University.

Quantifiable outcome

• 42,000+ patients treated annually
• +3 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature6 records

Partnerships

17 partnerships are on record, tiered core, major and minor.

• UNICANCERcoreStrategic or Co-development PartnerCentre Léon Bérard is a member of UNICANCER, the national federation of 20 French cancer treatment centers. This partnership provides access to collaborative research programs, shared clinical trials infrastructure, and national coordination for cancer care standards.
• Hospices Civils de LyoncoreStrategic or Co-development PartnerJoint management of IHOPe (Institut d'Hématologie et d'Oncologie Pédiatrique), a specialized pediatric oncology hospital created and operated jointly by Hospices Civils de Lyon and Centre Léon Bérard, serving approximately 250 new pediatric patients annually.
• CRCL (Cancer Research Center of Lyon)coreStrategic or Co-development PartnerThe Plateforme de Gestion des Echantillons Biologiques (PGEB) is part of technological platforms used by CRCL research teams. PGEB provides biological samples for multiple research projects (BILI, PDC, LIBIL, CALME) and participates in LYriCAN personalized medicine programs.
• LYriCAN (INCa Label)coreStrategic or Co-development PartnerPGEB participates in LYriCAN programs including Profiler, MOST, PLANET for personalized cancer medicine as part of INCa-labeled research consortium.
• MESOBANKmajorStrategic or Co-development PartnerHosting 900 samples (5,000 tubes) for mesothelioma research as part of INCa-labeled MESOBANK clinico-biological database. Collection includes 27,000+ FFPE blocks and 5,000 frozen samples.
• UNICANCER BiobankmajorStrategic or Co-development PartnerHosting 69,100 samples (169,700 tubes) for the UNICANCER biobank network, preparing samples for numerous projects including SAFIR-02, TRACER-X, and TOP-UP clinical trials.
• CIRC-IARC (International Agency for Research on Cancer)majorStrategic or Co-development PartnerCollaboration with WHO's cancer research agency on LUNGNENOMICS and MESOMICS research projects using biological samples from the center's collections.
• SHARE4kidsmajorStrategic or Co-development PartnerHosting pediatric biobank collections for SHARE4kids consortium focused on childhood cancer research and treatment development.
• LabTAU (Institut de chirurgie expérimentale)coreTechnology or IntegrationExperimental surgery institute (Inserm U1032, UCBL, CLB) working on computer simulations and modeling for radiotherapy and ultrasound treatment optimization using the 3R principle (Replace, Reduce, Refine).
• GIRCORminorStrategic or Co-development PartnerFrench association grouping public and private research actors using animals for scientific purposes. Centre Léon Bérard is a signatory of the Transparency Charter since 2021.
• ITCC (Innovative Therapies for Children with Cancer)coreStrategic or Co-development PartnerIHOPe is a member of ITCC consortium, one of few centers accredited for promoting ITCC pediatric oncology clinical trials.
• ERN PedCan (European Reference Network for Paediatric Cancer)coreStrategic or Co-development PartnerIHOPe participates in ERN PedCan, the European Reference Network for rare pediatric cancers, facilitating international cooperation and expertise sharing.
• ERN EURACAN (European Reference Network for Rare Adult Solid Cancers)coreStrategic or Co-development PartnerCentre Léon Bérard participates in EURACAN network for rare adult solid cancers, providing expertise sharing across European centers.
• C3D (Centre de découverte et de développement de médicaments)coreTechnology or IntegrationDrug discovery and development center performing large-scale screening of new molecules in vitro, supporting cancer treatment research.
• Plateforme Ex-vivomajorTechnology or IntegrationPlatform providing fresh tissue samples for research, collaborating with PGEB for sample management and distribution.
• Plateforme de Radiothérapie-Créatis (UMR CNRS 5220, Inserm U 1044)coreTechnology or IntegrationResearch unit performing computer simulations and modeling to optimize radiotherapy treatment parameters and ultrasound treatments.
• Université Lyon 1coreStrategic or Co-development PartnerPartnership with Claude Bernard Lyon 1 University for medical education, training of future doctors, nurses, and researchers, and collaborative research programs.

Scale indicators16 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Institut Bergonié: UNICANCER comprehensive cancer center in Bordeaux covering adult oncology and clinical research. Comparable size to other UNICANCER centers; competes with Léon Bérard for south-western French oncology demand, research funding, and industry-sponsored studies.
• European Institute of Oncology (IEO): Milan-based private non-profit comprehensive cancer center offering medical, surgical, and radiation oncology alongside translational research and early-phase trials. Comparable integrated mission and international patient focus, providing a cross-border benchmark for Léon Bérard's ambitions.
• Centre François Baclesse: Normandy-based UNICANCER center delivering medical oncology, radiotherapy, surgery, and clinical research. Closely matches Léon Bérard's service mix and federation role, despite a smaller national profile.
• European Cancer Centre - Charité Comprehensive Cancer Center: Berlin-based comprehensive cancer center jointly run by Charité university hospital and partner research institutes. Shares the integrated care-research-teaching model, comparable scale, and similar federalized European academic medicine context — a direct continental peer for capability benchmarking.
• Institut Paoli-Calmettes: UNICANCER comprehensive cancer center in Marseille providing specialist adult oncology care, research, and teaching. Closely comparable mission profile to Léon Bérard at slightly larger scale, competing for French Mediterranean referrals and cross-border patient flows.
• Institut Gustave Roussy: France's largest comprehensive cancer center (also UNICANCER member), combining adult oncology care, research, and teaching on a single campus. Most directly comparable to Léon Bérard in mission, scale, and federation alignment, competing for patients, trials, and visibility across the French oncology ecosystem.
• Institut Curie: Paris-based UNICANCER center integrating cancer hospital, research center, and hospital-based research (RHUs). Comparable care-plus-research footprint with strong brand equity and advanced radiotherapy/biology programs; competes with Léon Bérard for national and international patients and for top-tier trial sponsorships.
• Vall d'Hebron Institute of Oncology (VHIO): Translational oncology research institute co-located with Vall d'Hebron University Hospital in Barcelona. Comparable in combining early-phase clinical research with a high-volume hospital, and a peer for EU-funded precision-oncology programs that overlap with Léon Bérard's CRCL/LYriCAN participation.
• Institut de Cancérologie de l'Ouest: UNICANCER cancer center with sites in Nantes and Angers offering comprehensive medical, radiation, and surgical oncology plus research. Direct peer for adult oncology services, clinical trials, and regional referral competition, particularly within western France.
• Institut Régional du Cancer (IRCCS) - IFO Regina Elena: Italian comprehensive cancer center in Rome combining inpatient oncology care, translational research, and clinical trials. Comparable to Léon Bérard in scope and academic integration, operating in a different national health system but a similar European non-hospital model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@centrelberard
• Xx.com/CLCCLeonBerard

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Subsidiaries3 records

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Léon Bérard Center